The Mortar & Pestle is a podcast for all things compounding pharmacy. Its goal is to educate listeners on a wide variety of subjects that affect compounding pharmacies and the patients they serve, including clinical information, regulatory developments and marketing best practices, among others. Co-hosted by Mike DeLisio and Sebastian Denison, RPh.
All content for The Mortar & Pestle is the property of PCCA - The Leader in Compounding Pharmacy and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Mortar & Pestle is a podcast for all things compounding pharmacy. Its goal is to educate listeners on a wide variety of subjects that affect compounding pharmacies and the patients they serve, including clinical information, regulatory developments and marketing best practices, among others. Co-hosted by Mike DeLisio and Sebastian Denison, RPh.
In this episode of The Mortar & Pestle: A PCCA Podcast, host Mike de Lisio is joined by PCCA’s VP of R&D, Daniel Banov, and returning guest Richie Ray, owner of Richie Specialty Pharmacy, to explore the innovation and impact of SubMagna—a proprietary sublingual base developed by PCCA. They discuss the technical challenges and scientific breakthroughs involved in formulating SubMagna to effectively deliver high molecular weight peptides like semaglutide via the sublingual route. Daniel details the base’s development process, including surfactant balancing, solubility enhancement, and permeability optimization, while Richie shares clinical insights, patient responses, and the broader market implications. Together, they highlight SubMagna’s potential as a game-changing delivery system for peptides and other challenging APIs, especially in an era of rising demand for non-injectable therapies.
The Mortar & Pestle
The Mortar & Pestle is a podcast for all things compounding pharmacy. Its goal is to educate listeners on a wide variety of subjects that affect compounding pharmacies and the patients they serve, including clinical information, regulatory developments and marketing best practices, among others. Co-hosted by Mike DeLisio and Sebastian Denison, RPh.
